Nuclear Energy Is Back on the Agenda: Can Small Modular Reactors Power the Next Industrial Revolution?
Electricity demand is accelerating for the first time in a generation, and nuclear power is returning to the conversation. The IEA expects global demand to grow at 3.6% a year over 2026-2030, driven by industry, electric vehicles, air conditioning and data centres. In the United States, around half of the projected increase comes from data centres. Small modular reactors (SMRs) are the technology many investors and policymakers now point to for firm, low-carbon power. The question is whether they can deliver at industrial scale, and when.
Inside this article
1. What is a small modular reactor?
A small modular reactor is a nuclear reactor of limited output, typically a few hundred megawatts, designed to be built largely from factory-made modules rather than assembled on site. The promise is shorter construction, lower financing risk and more flexible siting than conventional large reactors. The IEA notes that SMRs could lower financing costs, and that with the right support installations could reach 80 GW by 2040, about 10% of global nuclear capacity.
2. Why are companies and governments turning to SMRs now?
Demand for firm power. The IEA identifies private-sector demand for firm, dispatchable and clean power as a major driver, with plans of varying maturity for up to 25 GW of SMR capacity, largely to serve data centres.
Policy backing. US policy now seeks to expand nuclear capacity from around 100 GW to 400 GW by 2050. Executive orders signed in May 2025 direct the NRC to streamline licensing and the DOE to speed reactor demonstration.
Hyperscaler procurement. Technology companies are signing long-term deals. Google agreed with Kairos Power to add around 500 MW from seven small reactors by the end of the decade. Amazon led a USD 500 million financing round in X-energy. Meta announced agreements in January 2026 covering up to 6.6 GW of nuclear capacity through 2035. Microsoft's deal for the Three Mile Island Unit 1 restart covers 835 MW, a restart rather than an SMR, but part of the same demand signal.
3. Where does SMR deployment actually stand?
| Area | Current position |
|---|---|
| First Western grid-scale SMR | Ontario Power Generation's BWRX-300 at Darlington received a construction licence in April 2025, with commercial operation targeted around 2030 |
| Schedule and cost | In November 2026 OPG said the first unit will not be completed within the previously planned timeline or cost |
| US test reactors | Antares and Valar Atomics reached criticality in June, Deployable Energy and Aalo followed around July 4 under DOE programmes |
| IEA outlook | First commercial SMR projects start operating around 2030; 40 GW by 2050 under today's policy settings |
Reaching criticality in a test reactor is not the same as delivering commercial power. Critics argue the DOE pilot route is not a substitute for NRC approval and does not by itself add meaningful new capacity.
4. What could hold SMRs back?
Cost and first-of-a-kind risk. NuScale and UAMPS terminated what would have been the first US commercial SMR after rising costs, including a projected power price increase of 53%. Darlington's revised outlook shows the risk has not disappeared.
Fuel supply. Many advanced designs depend on high-assay low-enriched uranium (HALEU). A GAO report published in August 2026 found that estimated supply may not meet near-term demand, even after DOE awarded USD 1.8 billion to two companies to build capacity.
Timelines. Analysts have described Google's 2030 target as very optimistic. Industrial users planning around SMR power should treat the early 2030s as the earliest realistic window.
5. Industry insight: what the evidence suggests
Three patterns stand out.
- Demand is not the constraint. Offtake interest is strong, with the IEA reporting agreements and expressions of interest for 30 GW of SMRs, mainly for data centres.
- Delivery is. Licences, fuel and first-of-a-kind construction determine the pace, not buyer appetite.
- Winners will be defined by execution. Designs with licences, secured fuel and financed offtake are better placed than those with announcements alone.
For strategy teams, this argues for tracking milestones such as licence decisions, fuel contracts and construction progress rather than headline megawatt pledges.
6. Frequently asked questions
What is an SMR in simple terms?
A small modular reactor is a compact nuclear reactor designed to be built largely from factory-made modules, aiming for faster construction and more flexible siting than large plants.
When will SMRs be operating commercially?
The IEA says the first commercial SMR projects are set to start operating around 2030. Ontario's Darlington unit targets about 2030 but has been flagged for schedule and cost revision.
Why are tech companies investing in SMRs?
Data centres need firm, clean, round-the-clock power. Google, Amazon and Meta have signed or backed nuclear and SMR deals to secure it.
Are SMRs cheaper than large reactors?
That is not yet proven. Early projects have faced cost pressure, including NuScale's cancelled Utah project, so cost claims should be treated cautiously until more units are built.
What is HALEU and why does it matter?
High-assay low-enriched uranium is fuel required by many advanced reactor designs. The GAO found estimated supply may not meet near-term demand.
Can SMRs power the next industrial revolution?
They can contribute firm low-carbon power from the early 2030s, but the evidence does not yet show that they can scale quickly. The IEA's range, 40 GW by 2050 under current policy and 80 GW by 2040 with strong support, shows how much depends on policy and delivery.
7. Conclusion
SMRs have real momentum: policy support, hyperscaler demand and the first construction in the West. They also face unresolved cost, fuel and schedule risk. Their likely role is as one source of firm power from around 2030 onward, not an overnight fix. Organisations planning around nuclear should track licences, fuel and construction milestones, and keep a diversified power strategy until those risks are retired.
About Apothium AI
Apothium AI brings together artificial intelligence, primary research and expert intelligence to support pharmaceutical and biotechnology organisations in making informed clinical and commercial decisions.
Through AI-driven insight generation, market and competitive intelligence, KOL intelligence and commercial strategy capabilities, Apothium AI helps life sciences teams navigate complex markets and identify emerging opportunities.
Explore Apothium AI to learn more about its intelligence capabilities.
Explore our capabilities: Market & Competitive Intelligence | Commercial Strategy Intelligence | AI-Driven Insight Generation